Financings in Brief: Angeion
This article was originally published in The Gray Sheet
Executive Summary
Angeion: Plans secondary offering of 5 mil. shares through Raymond James and Associates, NatWest Securities Limited, and Salomon Brothers. The Minneapolis-based manufacturer of defibrillators and radio frequency catheter ablation devices says proceeds will support "expansion of clinical trials, research and development, scale-up and expansion of the company's manufacturing and marketing, potential acquisitions of businesses, products and technologies, and general corporate purposes, including working capital"...